John Musser, MS is an Associate Director at Gilead with more than 19 years of experience in clinical research across sponsor, CRO, academic, and community oncology settings. He is a recognized leader in site engagement, clinical operations, and strategic partnerships, with expertise spanning trial feasibility, site selection, study startup, oncology and inflammatory research, and advanced therapies. Throughout his career, John has held leadership roles at Gilead, AstraZeneca, Regeneron, LabCorp Drug Development, Florida Cancer Specialists, and Moffitt Cancer Center. He is a frequent industry speaker advocating for stronger sponsor site collaboration and improved clinical trial execution.
